The Inflation Reduction Act & its Impact on Medicare - Capital Region BioPharma In-House Counsel Group
Jan 24 2023
12:00 AM
Linda Pissott Reig, shareholder, and Natalie Oehlers, associate, both in the firm's FDA & Life Sciences practice group, presented a CLE program entitled, “The Inflation Reduction Act & its Impact on Medicare" to the Capital Region BioPharma In-House Counsel Group. The session focused on four key topics within the IRA that directly affect the life sciences industry:
- Medicare Drug Price Negotiation program
- Medicare Inflationary Rebates
- Delay to the Trump Rebate Rule
- Medicare Part D Design Changes
Professionals
Related Services & Industries
Related Offices